Copy to clipboard 
Cirtec Medical,outsourcing partner for complex minimally invasive, active implantable devices and precision components, is pleased to announce the appointment of Shar Matin as Chief Executive Officer, effective September 2, 2025.
In support of orthopedic device companies, Cirtec provides concept-to-commercialization support—combining titanium machining, polymer molding, hermetic sealing and wireless telemetry integration in a single, controlled supply chain.
Mr. Matin brings more than 25 years of global leadership experience in the medical technology sector, with a track record of scaling businesses, driving innovation and building strong customer partnerships. He most recently served as CEO of Cordis, where he led the successful transformation from a division of Cardinal Health to one of the world’s largest pure-play cardiovascular companies.
“Shar is an experienced leader with a demonstrated ability to accelerate growth, strengthen customer partnerships, and drive innovation,” said Rich Relyea, Cirtec Board member and 3i Private Equity Partner. “On behalf of the Board, we are excited to welcome him to Cirtec and are confident he will build on the company’s strong foundation and help shape its next chapter of success.”
Reflecting on his appointment, Shar shared: “Cirtec has tremendous momentum, and I am humbled and privileged to lead the company into its next phase of growth while building on the incredible foundation already in place. Together with our teammates and as a trusted partner to our customers, I look forward to fulfilling our mission of bringing life-changing medical technologies to market for the betterment of patient care.”
The Cirtec Board of Directors also expressed its gratitude to Brian Highley for his leadership of Cirtec over the past decade. “Brian transformed Cirtec over the course of 11 years into an industry-leading CDMO with remarkable growth and expansion. His vision and commitment have been instrumental in establishing Cirtec as a trusted partner to some of the world’s most innovative medical technology companies, and we thank Brian for all of his contributions to building Cirtec into the leader that it is today.”
The Board also thanks Ed Philbin, who served as Interim CEO over the past several months, for his leadership during the transition period. His dedication and support have been key in continuing Cirtec’s momentum and delivering a seamless handover to new leadership.
Source: Cirtec Medical
